Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jalal Siddiqui

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Translational Oncology|August 13, 2021
RNA editing signatures identify melanoma patients who respond to Pembrolizumab or Nivolumab treatmentJalal Siddiqui, Wayne O Miles
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2019
Integration of Metabolomics and Transcriptomics to Identify Gene-Metabolite Relationships Specific to PhenotypeAndrew Patt, Jalal Siddiqui, Bofei Zhang, et al.
BMC Genomics|April 8, 2025
A computational HLA allele-typing protocol to de-noise and leverage nanopore amplicon dataJalal Siddiqui, Rohita Sinha, James Grantham, et al.
Scientific Reports|March 9, 2022
Mass COVID-19 patient screening using UvsX and UvsY mediated DNA recombination and high throughput parallel sequencingDario Palmieri, Amanda Javorina, Jalal Siddiqui, et al.
Cytotherapy|June 4, 2026
A pilot study of the CMV inSIGHT T-cell immunity panel to assess cytomegalovirus (CMV) cell mediated immunity (CMI) in allogeneic hematopoietic cell transplant (HCT) recipientsSwarn Arya, Rich Kodama, Yuxuan Li, et al.
Molecular Oncology|July 15, 2022
Slit2/Robo1 signaling inhibits small-cell lung cancer by targeting β-catenin signaling in tumor cells and macrophagesDinesh K Ahirwar, Bo Peng, Manish Charan, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 9, 2022
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironmentSanjay Mishra, Manish Charan, Rajni Kant Shukla, et al.
International Journal of Molecular Sciences|January 11, 2022
Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer CellsRobert J Rabelo-Fernández, Ginette S Santiago-Sánchez, Rohit K Sharma, et al.
Communications Biology|August 18, 2021
Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknessesSwetha Rajasekaran, Jalal Siddiqui, Jessica Rakijas, et al.
Communications Biology|October 1, 2021
Author Correction: Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknessesSwetha Rajasekaran, Jalal Siddiqui, Jessica Rakijas, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Translational Oncology|August 13, 2021
RNA editing signatures identify melanoma patients who respond to Pembrolizumab or Nivolumab treatmentJalal Siddiqui, Wayne O Miles
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2019
Integration of Metabolomics and Transcriptomics to Identify Gene-Metabolite Relationships Specific to PhenotypeAndrew Patt, Jalal Siddiqui, Bofei Zhang, et al.
BMC Genomics|April 8, 2025
A computational HLA allele-typing protocol to de-noise and leverage nanopore amplicon dataJalal Siddiqui, Rohita Sinha, James Grantham, et al.
Scientific Reports|March 9, 2022
Mass COVID-19 patient screening using UvsX and UvsY mediated DNA recombination and high throughput parallel sequencingDario Palmieri, Amanda Javorina, Jalal Siddiqui, et al.
Cytotherapy|June 4, 2026
A pilot study of the CMV inSIGHT T-cell immunity panel to assess cytomegalovirus (CMV) cell mediated immunity (CMI) in allogeneic hematopoietic cell transplant (HCT) recipientsSwarn Arya, Rich Kodama, Yuxuan Li, et al.
Molecular Oncology|July 15, 2022
Slit2/Robo1 signaling inhibits small-cell lung cancer by targeting β-catenin signaling in tumor cells and macrophagesDinesh K Ahirwar, Bo Peng, Manish Charan, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 9, 2022
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironmentSanjay Mishra, Manish Charan, Rajni Kant Shukla, et al.
International Journal of Molecular Sciences|January 11, 2022
Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer CellsRobert J Rabelo-Fernández, Ginette S Santiago-Sánchez, Rohit K Sharma, et al.
Communications Biology|August 18, 2021
Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknessesSwetha Rajasekaran, Jalal Siddiqui, Jessica Rakijas, et al.
Communications Biology|October 1, 2021
Author Correction: Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknessesSwetha Rajasekaran, Jalal Siddiqui, Jessica Rakijas, et al.
Pageof 1